2CQ-21472-80959
2 vaccinations
11 coded responses
30 check-ins
11 free-text entries
8 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 973 / OR
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-08
Health check-in — day 0, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Ear discomfort, Sinus disorder — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesFree text: Congestion in ears and sinusesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 1MedDRA: Heart rate increased, Hypoaesthesia, Hypoaesthesia oral, Speech disorder developmental — Feeling: Poor · Site: Pain, Itching · Headache, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Tongue, lip, face numbness, accelerated heart rate, cognitive lag in speechMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Itching · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitAdult check-in
-
2021-04-13
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-14
Survey response — days 1–6 daily, dose 1MedDRA: Office visit, Pain in extremity — Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Leg pain · Healthcare visit (other): Behavioral Health Consultation about medical traumaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-15
Survey response — day 7, dose 1MedDRA: Muscle spasms, Pain in extremity — Feeling: Fair · Headache, Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesFree text: Leg pain and crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
-
2021-04-29
Survey response — day 21, single doseMedDRA: Dizziness, Headache, Visual impairment — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Severe persistent headache, vision change, dizziness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — day 21, single doseBe unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-06
-
2021-05-13
Survey response — day 35, single doseMedDRA: Mass — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Lump in legMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — day 35, single doseBe unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-20
- 2021-06-10
-
2021-06-15
Call successfulCompleted over the phone
- 2021-07-10
- 2021-10-07
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-04
-
2021-12-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Muscle or body aches, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-12-08
-
2021-12-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Respiratory tract congestion — Feeling: FairFree text: Stuffy and swollen lymph's in neckMedDRA releases: 2024-11 · check-in free text available
- 2021-12-10
- 2021-12-11
-
2021-12-18
Survey response — day 14, dose 2MedDRA: Cough, Dyspnoea, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Lung shortness of breath and coughMedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Survey response — day 21, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid 19MedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Report sent to call center — day 21, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-28
Call successfulCompleted over the phone
-
2022-01-03
Survey response — day 28, dose 2MedDRA: Costochondritis, Dyspnoea, Fatigue, Headache, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Costochondritis, shortness of breath, fatigue, headache, body painMedDRA releases: 2024-11 · check-in free text available
-
2022-01-03
Report sent to call center — day 28, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-01-08
- 2022-01-15
- 2022-03-07
- 2022-06-04
-
2022-12-04
Survey response — 12 months, dose 2MedDRA: COVID-19, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Had a bad bug, not sure if it was Covid (didn't show up on tests) but symptoms were similarMedDRA releases: 2024-11 · check-in free text available
-
2022-12-04
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-12 | Successful | Completed over the phone |
| 2021-04-13 | Successful | Completed over the phone |
| 2021-04-14 | Successful | Completed over the phone |
| 2021-04-29 | Successful | Completed over the phone |
| 2021-05-13 | Successful 2021-06-15 |
Completed over the phone |
| 2021-12-25 | Successful 2021-12-28 |
Completed over the phone |
| 2022-01-03 | Successful | Completed over the phone |
| 2022-12-04 | Unsuccessful | Reported to VAERS during previous contact from GDIT |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Congestion in ears and sinuses
Systemic reaction (other): Tongue, lip, face numbness, accelerated heart rate, cognitive lag in speech
Systemic reaction (other): Leg pain
Healthcare visit (other): Behavioral Health Consultation about medical trauma
Release 7 — day 7, dose 1
Systemic reaction (other): Leg pain and cramps
Release 8 — day 21, single dose
Symptoms: Severe persistent headache, vision change, dizziness.
Release 8 — day 35, single dose
Symptoms: Lump in leg
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Stuffy and swollen lymph's in neck
Release 10 — day 14, dose 2
Symptoms: Lung shortness of breath and cough
Release 10 — day 21, dose 2
Symptoms: Covid 19
Release 10 — day 28, dose 2
Symptoms: Costochondritis, shortness of breath, fatigue, headache, body pain
Release 12 — 12 months, dose 2
Symptoms: Had a bad bug, not sure if it was Covid (didn't show up on tests) but symptoms were similar
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Costochondritis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Mass | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Visual impairment | ✓ | ✓ | ✓ |
| SRO | Ear discomfort | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia oral | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Sinus disorder | ✓ | ✓ | ✓ |
| SRO | Speech disorder developmental | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release